市场调查报告书
商品编码
1151889
全球医用大麻市场规模研究与预测,按配方类型(胶囊,油,其他),应用(慢性疼痛,关节炎,偏头痛,癌症,其他用途)、区域分析2022-2029Global Medical Marijuana Market Size study & Forecast, by Formulation Type (Capsules, Oils, and Other Formulation Types) by Application (Chronic Pain, Arthritis, Migraine, Cancer, and Other Applications) and Regional Analysis, 2022-2029 |
2021 年全球医用大麻市场价值约为 110 亿美元,预计在 2022-2029 年的预测期内将以超过 21.06% 的增长率增长。
医用大麻,也称为医用大麻,源自植物大麻,也用于治疗疾病和某些病症,例如癌症、慢性疼痛、精神疾病和疼痛管理。。医用大麻有两种类型:来自西半球的大麻和来自中亚和南亚的大麻。市场增长的主要推动力是人们越来越意识到医用大麻的好处,整个地区的大麻合法化程度不断提高,以及 FDA 对医用大麻产品的批准不断增加。
2018 年,FDA 批准了第一种含有源自大麻的活性成分的药物,用于治疗癫痫。 Epidiolex(大麻二酚)[CBD]口服溶液获得批准用于治疗两种严重且罕见的癫痫相关癫痫发作:Lennox-Gastaut 综合征和 Dravet 综合征。 2018年1月,澳大利亚政府允许澳大利亚大麻生产商向全球医用大麻市场出口医用大麻及其产品。此外,随着研发活动的增加,创新产品的开发将在预测期内为市场创造有利可图的机会。然而,关于大麻使用的复杂监管结构将阻碍整个 2022-2029 年预测期内的市场增长。
全球医用大麻市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于美国大麻合法化的进展,北美已成为市场份额第一的地区。由于大麻合法化程度的提高以及可支配收入增加、社会接受度和消费者对产品益处的了解等因素,预计亚太地区在预测期内将呈现高速增长。
本报告中包含的主要市场参与者包括:
市场的最新发展
全球医用大麻市场研究范围
历史数据:2019-2020-2021
基准估计年份:2021
预测时间:2022-2029
报告涵盖的收入预测、公司排名、竞争格局、增长因素、趋势
目标细分市场製剂类型、应用、地区
区域范围北美、欧洲、亚太地区、拉丁美洲、世界其他地区
购买后可免费定制覆盖率报告(相当于最多 8 个分析师小时)。添加或更改国家、地区、细分范围*
这项研究的目的是定义近年来各个细分市场和国家的市场规模,并预测他们在未来几年的价值。该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。市场的详细细分和子细分如下所述。
按配方类型
胶囊
石油
其他配方类型
按申请
慢性疼痛
关节炎
偏头痛
癌症
其他用途
按地区
北美
美国
加拿大
欧洲
英国
德国
法国
西班牙
意大利
其他欧洲
亚太地区
中国
印度
日本
澳大利亚
韩国
其他亚太地区
拉丁美洲
巴西
墨西哥
世界其他地区
Global Medical Marijuana Market is valued approximately at USD 11.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 21.06% over the forecast period 2022-2029. Medical marijuana, also referred to as medical cannabis, is derived from the Cannabis sativa plant which is also used to treat a disease or specific symptom such as cancer, chronic pain, mental disorders, and manage pain. Cannabis Sativa and Cannabis Indica, which come from the western hemisphere and central and south Asian regions, respectively, are the two types of medical marijuana. The key factors driving the market growth is rising awareness about benefits of medical marijuana, growing legalization of cannabis across region and growing FDA approvals for medicinal cannabis products.
In 2018, FDA approved the first drug comprising of an active component derived from marijuana for treating epilepsy. Epidiolex (cannabidiol) [CBD] in oral solution was granted this approval to treat seizures related to two severe and rare forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. In January 2018, the Australian Government allowed marijuana producers in the country to export medical marijuana and its products to the global medical marijuana market. Also, innovative product development with growing R&D activities will create lucrative opportunities for the market during forecast period. However, the complex regulatory structure for the usage of cannabis stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Medical Marijuana Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising cannabis legalization in the U.S. This is one of the key factors contributing to its growing demand. Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing legalization of cannabis as well as an increase in disposable income, social acceptance, and consumer understanding of the product's advantages.
Major market players included in this report are:
Tilray
Aurora Cannabis
Canopy Growth Corporation
Aphria, Inc.
Maricann Group, Inc.
Tikun Olam, Ltd.
MedReleaf. Corp.
GW Pharmaceuticals plc.
Cannabis Sativa, Inc.
Medical Marijuana, Inc.
Recent Developments in the Market:
Global Medical Marijuana Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Formulation Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Formulation Type:
Capsules
Oils
Other Formulation Types
By Application:
Chronic Pain
Arthritis
Migraine
Cancer
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable